Bent Frandsen

Filings at 7 companies/Chief executive officer · Expres2ion Biotech Holding AB

5 of 20 shown

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings by this filer, out of 20. Reading the whole list, and the full company page behind every filing, is part of the subscription. So are this filer’s key figures — how many filings and open-market purchases they reported, and over which period — and the price change beside each line, since the filing and since the trade. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The 5 most recent of 20 visible filings, newest first.

Expres2ion Biotech Holding AB Chief executive officer
11,000 SEKOpen-market buy
TradedOct 9, 2026FiledOct 9, 2026
Expres2ion Biotech Holding AB Chief executive officer
11,000 SEKOpen-market buy
TradedOct 9, 2026FiledOct 9, 2026
Expres2ion Biotech Holding AB Chief executive officer
9,200 SEKOpen-market buy
TradedOct 2, 2026FiledOct 2, 2026
Expres2ion Biotech Holding AB Chief executive officer
14,280 SEKOpen-market buy
TradedOct 1, 2026FiledOct 2, 2026
ExpreS2ion Biotech Holding AB Chief executive officer
2,883,120 SEKOption exercise
TradedOct 2, 2025FiledOct 2, 2025